1079 Type I interferon regulation by USP18 is a key vulnerability in cancer

• Feng Wang,
• Bing Yang,
• Benedikt M Kessler,
• Veronica Jove,
• Heather Wheeler,
• Chiachin Wilson Lee,
• David R Healy,
• Kymberly Levine,
• Erik C Ralph,
• Anand Giddabasappa,
• Paula Loria,
• Masaya Yamaguchi,
• Agustin Casimiro-Garcia,
• Adan Pinto-Fernandez,
• Veronique Frattini,
• Paul Wes

Affiliations

Feng Wang

The Chinese University of Hong Kong, Hong Kong

Bing Yang

Department of Neurology, Jinan University First Affiliated Hospital, Guangzhou, Guangdong, China

Benedikt M Kessler

6Nuffield Department of Medicine, Target Discovery Institute, University of Oxford, Oxford, UK

Veronica Jove

1Pfizer, New York, NY, USA

Heather Wheeler

2Pfizer, Groton, CT, USA

Chiachin Wilson Lee

2Pfizer, Groton, CT, USA

David R Healy

2Pfizer, Groton, CT, USA

Kymberly Levine

2Pfizer, Groton, CT, USA

Erik C Ralph

2Pfizer, Groton, CT, USA

Anand Giddabasappa

3Pfizer, La Jolla, CA, USA

Paula Loria

2Pfizer, Groton, CT, USA

Masaya Yamaguchi

2Pfizer, Groton, CT, USA

Agustin Casimiro-Garcia

4Pfizer, Cambridge, MA, USA

Adan Pinto-Fernandez

5University of Oxford, Oxford, Oxfordshire, UK

Veronique Frattini

1Pfizer, New York, NY, USA

Paul Wes

2Pfizer, Groton, CT, USA